Protein kinase C-ε protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation

Carswell EA, Old LJ, Kassel RL et al (1975) An endotoxin induced serum factor that causes necrosis of tumors. Procnatacadsciusa 72:3666–3670 Lewis M, Tartaglia LA, Lee A et al (1991) Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 88:2830–2834 Schall TJ, Lewis M, Koller KJ et al (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361–370 Sugarman BJ, Aggarwal BB, Hass PE et al (1985) Recombinant human tumor necrosis factor-[alpha]: effects on proliferation of normal and transformed cells in vitro. Science 230:943–945 Creasey AA, Yamamoto R, Vitt CR (1987) A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. Proc Natl Acad Sci USA 84:3293–3297 Smith CA, Davis T, Anderson D et al (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019–1023 Salvesen GS, Dixit VM (1997) Caspases: intracellular signaling by proteolysis. Cell 91:443–446 Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281:1312–1316 Kischkel FC, Hellbardt S, Behrmann I et al (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579–5588 Krammer PH (2000) CD95’s deadly mission in the immune system. Nature 407:789–795 Eskes R, Desagher S, Antonsson B, Martinou JC (2000) Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20:929–935 Gross A, Yin XM, Wang K et al (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274:1156–1163 Rudner J, Jendrossek V, Lauber K, Daniel PT, Wesselborg S, Belka C (2005) Type I and type II reactions in TRAIL-induced apoptosis – results from dose–response studies. Oncogene 24:130–140 Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ (1996) BID: a novel BH3 domain-only death agonist. Genes Dev 10:2859–2869 Hsu YT, Youle RJ (1998) Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 273:10777–10783 Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139:1281–1292 Cory S, Adams JM (2002) The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2:647–656 Gillespie S, Zhang XD, Hersey P (2005) Variable expression of protein kinase C epsilon in human melanoma cells regulates sensitivity to TRAIL-induced apoptosis. Mol Cancer Ther 4:668–676 Ravi R, Bedi A (2002) Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). Cancer Res 62:1583–1587 McJilton MA, Van Sikes C, Wescott GG et al (2003) Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells. Oncogene 22:7958–7968 Basu A, Lu D, Sun B, Moor AN, Akkaraju GR, Huang J (2002) Proteolytic activation of protein kinase C-epsilon by caspase-mediated processing and transduction of antiapoptotic signals. J Biol Chem 277:41850–41856 Lu D, Huang J, Basu A (2006) Protein kinase Cepsilon activates protein kinase B/Akt via DNA-PK to protect against tumor necrosis factor-alpha-induced cell death. J Biol Chem 281:22799–22807 Sivaprasad U, Shankar E, Basu A (2007) Downregulation of Bid is associated with PKCvarepsilon-mediated TRAIL resistance. Cell Death Differ 14:851–860 Basu A, Akkaraju GR (1999) Regulation of caspase activation and cis-diamminedichloroplatinum(II)-induced cell death by protein kinase C. Biochemistry 38:4245–4251 Gross A, Jockel J, Wei MC, Korsmeyer SJ (1998) Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J 17:3878–3885 Sundararajan R, White E (2001) E1B 19K blocks Bax oligomerization and tumor necrosis factor alpha-mediated apoptosis. J Virol 75:7506–7516 Cory S, Huang D, Adams J (2003) The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22:8590–8607 Antonsson B, Montessuit S, Sanchez B, Martinou J-C (2001) Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276:11615–11623 Gardai SJ, Hildeman DA, Frankel SK et al (2004) Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 279:21085–21095 Guo B, Zhai D, Cabezas E et al (2003) Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 423:456–461 Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S (2003) Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5:320–329 Nomura M, Shimizu S, Sugiyama T et al (2003) 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 278:2058–2065 Tsuruta F, Sunayama J, Mori Y et al (2004) JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J 23:1889–1899